Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
I've been in this since shortly after Bruno Jactel came on board and was fortunate to catch the huge rise in Feb 2014 when I sold the lot. Bought back in steadily as things progressed and for the life of me I cannot understand why the share price is where it is. Given the progress, especially with Vamousse, I believe this is well undervalued but the market is what it is. As you say, next month we'll see where they're at. I'm expecting somewhere intro $4.5m sales for the first half. Anything above that figure would be a big plus considering the 2nd half will always be better with their current offerings. ATB
Good post gg_man. The problem for Tyratech and their repellant is the cost. Your average South American doesn't have 7 or 8 $ to buy it. I can see it doing very well in the southern states and other developed areas of the world but those that really need it can't afford it.
Another thing, you say 2% market share....well for your info they already have 7% market share as stated by Bruno earlier in that youtube link. A good result would be 2-3% market share in year one so they are performing extremely well
Thoth2, You are completely wrong with your comments regarding inventory. Listen to this from 24' in... https://www.youtube.com/watch?v=crVqS1t24UM Bruno quite specifically states retailers carry very little inventory and are reordering on a weekly basis. There will be no credit notes and no returns as you state. Trading update expected this week, expect it to be very upbeat.
£9.16, that's right. Very very cheap for a company whose products are on Walmart's, Walgreens & CVS shelves, not to mention the UK. I see Vamousse on Amazon.co.uk is up to the #3 best selling lice treatment products, #8 in the USA. Time to grab market share & they did say they would use some of the placing monies to expand marketing. 2016 should be a very good year for this little diamond. GLA.
Tyratech is not capitalised at £5m. There are just short of 370m shares in issue after November's placing of 105m shares. Multiply the share price by 3.7 to arrive at the current market cap in millions. I expect we'll get a trading update before too much longer.
Too early for that imo, and it has also crossed miy mind more than once recently. You have hit a nail on the head though, Tyratech is in the process of creating a 'brand' and doing very nicely on that front. I think even one brand like Vamousse has to be worth multiples of the current market cap but I do think it will take another year or two before Vamousse is established as a successful brand. The current share price is truly laughable if you consider we just hit an all time low after penetrating both the USA & UK markets, becoming the 3rd best selling head lice treatment at Walmart. How this got to 3.5p on the offer is beyond me and I did take advantage of that special offer by buying 50k @ 3.48p. Thank you very much Mr. Market.
2 trades, 2 ticks. Just goes to show this can move up just as quickly as it came down.
Sorry, not sure where that Facebook page thing came from, autofill I suppose.
Quiet thread... I have been checking the customer reviews on the Amazon, Walmart & Walgreens websites.... 5* in the main with some astonishingly good reviews. This company is going places very soon in my opinion. I first heard of them when they announced Jactel was taking over as CEO & after much research I was convinced their offerings were something out of the ordinary. GLA.
hTTp://beefmagazine.com/novartis-animal-health-us-inc-introduces-natunex-non-toxic-biocides-insect-control "Our customers have requested a non-toxic and less restrictive alternative to chemical-based insecticides with increased frequency over the past few years,” added Bosch. “That’s why Novartis Animal Health is broadening its portfolio of pest control products to include Natunex biocides.”
I have been buying since the last RNS. Thank God there's a seller in the market and I don't say that too often. The Novartis news is bigger than many understand. It's a bit like running a corner shop and having John Lewis selling on your behalf nationwide. Cheap as chips again.
Ta very much BigC. Incidently, I'm now out of TYRU. It has, imo, gone too high considering first profits won't arrive until 2015 and we will have a market cap of £40m when the new shares hit the market. I still think it's a great company with a great future but sometimes these things get ahead of themselves. I'll be looking to re-enter once some of the froth has disappeared.
Hi again BigCO, I never got a reply from First Columbus unfortunately so I will take you up on the offer. I'll be mailing you. Thanks a lot. Going great here, let's hope it continues.
There aren't that many shares in issue... 51m TYRU & 117m TYR. Anyone wanting to buy these with a view to holding long term should go for the TYR shares which can be converted to TYRU shares after they have been held for a period of one year.
Sounds like you need Vamousse. To get in or not to get in....little downside methinks and the news flow should keep the share price moving up.
Hard to say whether there will be a dip. I thought after the rise yesterday we'd see some profit taking but the buyers keep on coming. I've been in this since September and I'm pretty sure there will be more news soon on distribution deals for the US/UK markets. The Walgreen pharmacy chain with 8500 outlets will, I'm sure, be one of them. They were also in discussions for a further 8500 through other chains. Then there's Walmart, Home Depot, Target & Amazon.... Think I'll hold. LOL
Anyone wanting a quick overview of what's on offer here should start by reading the news since Bruno Jactel joined the company in Jan. 2013. Take a look at his background then ask yourself why he would quit his job with a company with a multi-billion dollar turnover to join Tyratech. He is largely responsible for getting the likes of American Vanguard and Novartis on board. He saw the potential. Main events last year: January - New CEO March - American Vanguard take a 29.4% stake in the company & form JV August - Novartis distribution deal Recent - from the interims - preliminary agreement with Walgreen(it has to be Walgreen as they are the only pharmacy chain with as many as 8500 outlets) to sell Vamousse. Discussions ongoing with other pharmacy chains which could add a further 8500 outlets. Walmart, Amazon etc etc. Good luck if you're in.
Just what this share needed, a buy rec n the Daily Mail. Yes, bodes well for this coming week. Amazon? First I've heard of these discussions although they must announce something soon on UK distribution deal(s).
No interest whatsoever here? This Walmart deal should attract the rest of the major retailers in the USA. No mention of exclusivity. Next up I'd guess a similar deal with major supermarket chains/pharmacies. Novartis news can't be far off either.